O'Brien 1974.
Methods | Allocation: randomly assigned (code held by a technician who was not responsible for allocation). Blindness: double (identical capsules, coded bottles). Design: 2 parallel groups, 2 centres. Duration: 3 weeks. Analysis: intention‐to‐treat not performed in the trial. Country: USA. | |
Participants | Diagnosis: patients with symptoms of hostility, suspiciousness, paranoia and aggressiveness; 20 schizophrenics*. N=30. Age: mean ˜30 years. Sex: M 22, F 2. Setting: hospital. | |
Interventions | 1. Trifluoperazine: dose 9‐48 mg/day. N=15. 2. Haloperidol: dose 3‐20 mg/day. N=15. | |
Outcomes | Global state.
Leaving the study early.
Use of antiparkinson agents. Unable to use ‐ Mental state: (BPRS; Global Hostility; Global Paranoia ‐ no SD). Psychological Tests: (Buss‐Durkee hostility inventory; Rozenzweig picture frustration test; MMPI and Rorshach test ‐ no data). |
|
Notes | **Mixed diagnosis. | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment? | Low risk | A ‐ Adequate |